SCREENING GUIDELINES
For the general population,
breast cancer surveillance involves a combination of clinical breast
examinations and radiographic imaging. In 2002, the U.S. Preventative Service
Task Force (USPSTF) found insufficient evidence for or against breast
self-examinations (BSE). The American College of Obstetricians and
Gynecologists (2003) con-tinues to support the practice of BSE, because of the
potential ability to detect a palpable breast cancer. The value of clinical
breast examination in detecting breast cancer has also been studied. Pooled
data from multiple studies supports the use and effectiveness of clinical
breast examination. Multiple reviews have supported the combination of clinical
breast examination and mam-mography for breast cancer screening for women aged
50 to 69 years. ACOG supports the recommendations of the American Cancer
Society, which calls for clinical breast examinations every 3 years for women
aged 20 to 39, and annually thereafter
The value
of mammography increases with age. TheUSPSTF
found sufficient evidence to demonstrate that mammogram screening every 1 to 3
years significantly reduced mortality from breast cancer. Controversy exists
over screening intervals in younger women, where the incidence of breast cancer
remains low. ACOG and the USPSTF currently recommend that mammography be
performed every 1 to 2 years between ages 40 and 49, and annually thereafter.
These screening standards do not
apply to women with inherited genetic mutations placing them at increased risk
for developing breast cancer. In this
population, breastcancer occurs at a younger age and is missed by screening
mammography nearly 50% of the time. Current recom-mendations for BRCA
carriers includes monthly breast self-examinations beginning at ages 18 to 20,
annual clin-ical breast exams, and screening mammograms beginning after age 25
(or 5–10 years before the age of diagnosis in the affected relative). MRI is
recommended as a supple-ment to mammography, not a replacement.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.